Radiotherapy late effects in practice
Despite advancements in radiotherapy, many cancer survivors experience late effects that significantly impair quality of life, creating a growing burden on healthcare systems. Historically, focus has been on early diagnosis and acute toxicity, but attention is now shifting toward long-term consequences and patient-centred care. Late effects arise from radiation-induced fibrosis (RIF), a progressive condition causing tissue stiffening, nerve compression and functional loss. These complications vary by treatment site: pelvic radiation disease affects multiple systems, leading to gastrointestinal, urological and gynaecological dysfunction, chronic pain and structural damage; breast cancer treatment often results in localised fibrosis, lymphoedema and mobility issues; head and neck radiotherapy causes swallowing difficulties, oral pain, trismus and severe musculoskeletal and neurological impairments.
Effective management requires early identification, multidisciplinary late effects clinics, and education for both patients and professionals. Patient-reported outcome measures are vital for capturing lived experiences and guiding care. Rehabilitation strategies emphasise exercise adherence, psychosocial support and phased return to work to restore normality and improve wellbeing. However, sustainability of these services is threatened by reliance on charitable funding, underscoring the need for dedicated resources and standardised best practice guidelines. Emerging therapies, such as photobiomodulation, show promise in mitigating RIF.
Ultimately, equitable access to late effects services and ongoing research into mechanisms and treatments are essential. Collaborative, holistic approaches can validate patient concerns, reduce long-term morbidity and enhance survivorship outcomes.
To download and read this article as a pdf please sign up to our newsletter.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.
